Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

Sandip M. Prasad; Dimitar Shishkov; Nikola Vladimirov Mihaylov; Alexandre Khuskivadze; Pencho Genov; Vasyl Terzi; Max Kates; William C. Huang; Michael J. Louie; Sunil Raju; Brent Burger; Andrew Meads; Mark Schoenberg

doi:10.1097/JU.0000000000004296

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

Sandip M. Prasad
, Dimitar Shishkov
, Nikola Vladimirov Mihaylov
, Alexandre Khuskivadze
, Pencho Genov
, Vasyl Terzi
, Max Kates
, William C. Huang
, Michael J. Louie
, Sunil Raju
, Brent Burger
, Andrew Meads
, Mark Schoenberg

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	205-216
Number of pages	12
Journal	The Journal of urology
Volume	213
Issue number	2
DOIs	https://doi.org/10.1097/JU.0000000000004296
State	Published - Feb 1 2025
Externally published	Yes

ASJC Scopus Subject Areas

Urology

Keywords

ENVISION
LG-IR-NMIBC
chemoablation
recurrent bladder cancer

Access to Document

10.1097/JU.0000000000004296

OpenUrl availability

Full text

Cite this

Prasad, S. M., Shishkov, D., Mihaylov, N. V., Khuskivadze, A., Genov, P., Terzi, V., Kates, M., Huang, W. C., Louie, M. J., Raju, S., Burger, B., Meads, A., & Schoenberg, M. (2025). Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). The Journal of urology, 213(2), 205-216. https://doi.org/10.1097/JU.0000000000004296

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). / Prasad, Sandip M.; Shishkov, Dimitar; Mihaylov, Nikola Vladimirov et al.
In: The Journal of urology, Vol. 213, No. 2, 01.02.2025, p. 205-216.

Research output: Contribution to journal › Article › peer-review

Prasad, SM, Shishkov, D, Mihaylov, NV, Khuskivadze, A, Genov, P, Terzi, V, Kates, M, Huang, WC, Louie, MJ, Raju, S, Burger, B, Meads, A & Schoenberg, M 2025, 'Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)', The Journal of urology, vol. 213, no. 2, pp. 205-216. https://doi.org/10.1097/JU.0000000000004296

@article{6ffc27b73a794dc9b388aac589ea2a91,

title = "Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)",

keywords = "ENVISION, LG-IR-NMIBC, chemoablation, recurrent bladder cancer",

author = "Prasad, \{Sandip M.\} and Dimitar Shishkov and Mihaylov, \{Nikola Vladimirov\} and Alexandre Khuskivadze and Pencho Genov and Vasyl Terzi and Max Kates and Huang, \{William C.\} and Louie, \{Michael J.\} and Sunil Raju and Brent Burger and Andrew Meads and Mark Schoenberg",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published on behalf of the American Urological Association, Education and Research, Inc.",

year = "2025",

month = feb,

day = "1",

doi = "10.1097/JU.0000000000004296",

language = "English",

volume = "213",

pages = "205--216",

journal = "The Journal of urology",

issn = "0022-5347",

number = "2",

}

TY - JOUR

T1 - Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102

T2 - A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

AU - Prasad, Sandip M.

AU - Shishkov, Dimitar

AU - Mihaylov, Nikola Vladimirov

AU - Khuskivadze, Alexandre

AU - Genov, Pencho

AU - Terzi, Vasyl

AU - Kates, Max

AU - Huang, William C.

AU - Louie, Michael J.

AU - Raju, Sunil

AU - Burger, Brent

AU - Meads, Andrew

AU - Schoenberg, Mark

PY - 2025/2/1

Y1 - 2025/2/1

KW - ENVISION

KW - LG-IR-NMIBC

KW - chemoablation

KW - recurrent bladder cancer

UR - https://www.scopus.com/pages/publications/85209919782

UR - https://www.scopus.com/pages/publications/85209919782#tab=citedBy

U2 - 10.1097/JU.0000000000004296

DO - 10.1097/JU.0000000000004296

M3 - Article

C2 - 39446087

AN - SCOPUS:85209919782

SN - 0022-5347

VL - 213

SP - 205

EP - 216

JO - The Journal of urology

JF - The Journal of urology

IS - 2

ER -

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this